Skip to search.
 TSX Down 0.61% TSX Ventures Up 0.04%

Pluristem Therapeutics, Inc. (PSTI)

-NasdaqCM
2.76 Down 0.04(1.43%) May 29, 3:59PM EDT
Add to Portfolio
Prev Close:2.80
Open:2.79
Bid:N/A
Ask:2.92 x 5000
1y Target Est:5.50
Beta:-0.93
Next Earnings Date:N/A
Day's Range:2.75 - 2.83
52wk Range:2.32 - 3.78
Volume:37,777
Avg Vol (3m):141,390
Market Cap:196.64M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
PSTIDown 1.43%196.64M
ASTM 0.00%N/A
ACTC 0.00%N/A
OSIRDown 0.43%639.65M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):526.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.38
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related tech... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback